Follow The Filings

HOWL Werewolf Therapeutics

Werewolf Therapeutics earnings company data as of 7:49 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by HOWL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HOWL insider trades
  • None no insider bought on the open market
  • $964K sold by 1 insider outside a trading plan
  • $7.7M sold by 3 insiders under 10b5-1 plans
  1. Luke Evnin Director
    Planned sale
    $45K 143,199 shares at $0.3100 100% of stake
    Traded Jul 6–7 Filed Jul 8
    ↗
  2. Luke Evnin Director
    Planned sale
    $47K 157,084 shares at $0.3000 52% of stake
    Traded Jun 29 Filed Jun 29
    ↗
  3. Ra Capital Management, L.P. 10% owner, +3 joint filers
    Sale
    $146K 416,911 shares at $0.3500 58% of stake
    Traded Jun 17 Filed Jun 22
    ↗
  4. Ra Capital Management, L.P. 10% owner, +3 joint filers
    Sale
    $174K 448,836 shares at $0.3900 58% of stake
    Traded Jun 12–16 Filed Jun 16
    ↗
  5. Ra Capital Management, L.P. 10% owner, +3 joint filers
    Sale
    $254K 678,226 shares at $0.3700 65% of stake
    Traded Jun 9–11 Filed Jun 11
    ↗
  6. Luke Evnin Director
    Planned sale
    $28K 76,928 shares at $0.3700 20% of stake
    Traded Jun 9 Filed Jun 10
    ↗
  7. Luke Evnin Director
    Planned sale
    $43K 105,565 shares at $0.4100 22% of stake
    Traded Jun 4–8 Filed Jun 8
    ↗
  8. Luke Evnin Director
    Planned sale
    $64K 139,803 shares at $0.4600 23% of stake
    Traded Jun 1–3 Filed Jun 3
    ↗
  9. Luke Evnin Director
    Planned sale
    $66K 141,106 shares at $0.4700 19% of stake
    Traded May 27–29 Filed May 29
    ↗
  10. Luke Evnin Director
    Planned sale
    $87K 191,762 shares at $0.4500 20% of stake
    Traded May 21–26 Filed May 26
    ↗
  11. Luke Evnin Director
    Planned sale
    $76K 171,049 shares at $0.4500 15% of stake
    Traded May 18–20 Filed May 20
    ↗
  12. Luke Evnin Director
    Planned sale
    $24K 44,679 shares at $0.5400 3.8% of stake
    Traded May 13 Filed May 13
    ↗
  13. Ra Capital Management, L.P. 10% owner, +3 joint filers
    Sale
    $391K 565,167 shares at $0.6900 58% of stake
    Traded May 8–12 Filed May 12
    ↗
  14. Luke Evnin Director
    Planned sale
    $280K 407,574 shares at $0.6900 26% of stake
    Traded May 8–12 Filed May 12
    ↗
  15. Luke Evnin Director
    Planned sale
    $64K 100,581 shares at $0.6400 6% of stake
    Traded May 5–7 Filed May 7
    ↗

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
8-K 1.01,3.02,7.01,9.01 Filing Doc
8-K 1.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.